Defective Drugs--Digitek

Even after a drug is known to be defective, it can pose a threat to consumers.  This is the case with Digitek.  A lawsuit has been filed against manufacturers Totowa and Mylan Pharmaceuticals, stating the companies knew the drug was defective yet still released it in "safer" single doses.  Allegedly, the plaintiff's son received a double dose and died.  The prosecution believes the manufacturers had the responsibility to design, manufacture and sell safe drugs to the public.